New Study Confirms Ivermectin Outperforms Other Options
Tested on the Omicron variant, ivermectin outperformed 10 medications, including one approved for emergency use. Early treatment can lower hospitalization, mortality and symptoms of long COVID.
Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment
Ivermectin lowers the viral load by inhi…